GROL 9/7/2023 - Painful Beginnings: Measuring and Treating Pain in Newborn Infants

Thursday, September 7, 2023, 10:58 AM - Friday, December 1, 2023, 12:00 AM

Local, national, and international leaders present pediatric topics in their area of specialty during this weekly series.

AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours), ANCC Contact Hour(s) (0.00 hours), MATE Act Related Content (1.00 hours), KS Category III CME Related Content (1.00 hours)

1. Describe a variety of approaches that can be used to measured pain in newborn infants.
2. Explain how the measurement of pain can lead to better treatment options for infants.
3. Discuss the benefits of using brain-derived measures when measuring and treating pain in infants.
4. Recognize multiple factors that can influence pain in infancy.

Children's Mercy Hospital  designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation.

 

Accessibility Statement
 
Children's Mercy Kansas City is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

The Children's Mercy Kansas City Office of Continuing Medical Education adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Children's Mercy Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.